Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.
Glycologix has raised $800K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Glycologix's investors include Cortado Ventures.
Glycologix is headquartered in Beverly, United States.
Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.
Glycologix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Glycologix — Funding & Investors." VCBacked, December 29, 2025, https://www.vcbacked.co/company/glycologix. Accessed August 16, 2026.
VCBacked. (2025). Glycologix — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/glycologix
{{cite web |title=Glycologix — Funding & Investors |url=https://www.vcbacked.co/company/glycologix |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated